Jan 19 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* IMMUNOVIA REALIGNING SWEDISH OPERATIONS WITH STRATEGIC
PRIORITIES AND ITS FOCUS ON THE US COMMERCIALIZATION OF THE
IMMRAY™ PANCAN-D TEST
* IS REALIGNING ITS SWEDISH OPERATIONS WITH ITS STRATEGIC
PRIORITIES TO DRIVE RESEARCH AND DEVELOPMENT PRODUCTIVITY AND
FOCUS ON US COMMERCIALIZATION OF IMMRAY™ PANCAN-D TEST.
* HAS INITIATED A CONSULTATION PROCESS WITH RELEVANT SWEDISH
UNIONS TO CREATE BEST POSSIBLE TRANSITION FOR AFFECTED EMPLOYEES
* WILL PROVIDE AN UPDATE ONCE CONSULTATION PROCESS IS
CONCLUDED
Source text for Eikon: ID:nWkr2YD39C
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))